Supporting Video-Based Psychotherapy While Asking Who Benefits and Who Remains in Treatment.
- 1Graduate Program in Health and Behavior, Universidade Católica de Pelotas, Gonçalves Chaves Street, 373, 411 C, Pelotas, Rio Grande do Sul, 96015-560, Brazil, 55 53981180444, 55 5321288404.
Abstract
Unlabelled
Meyer-Keirath and colleagues found no significant difference in posttreatment symptoms between video-based and face-to-face psychotherapy. However, the wide confidence interval indicates substantial imprecision, while the prediction interval suggests that comparative effects may vary considerably across settings; neither supports a conclusion of equivalence. For health services, symptom outcomes alone tell only part of the story. Future studies should report, by randomized group, who starts treatment, who discontinues it, and who completes the final assessment. These are distinct outcomes that may differ between delivery formats and affect the interpretation of symptom results. Video-based psychotherapy is a reasonable option, but its value should be assessed across the full treatment pathway. Adequately powered noninferiority trials should identify which patients can access, remain in, and benefit from each format.
Related
- Psychotherapy remains a human endeavor: Human therapy is valued more than AI-integrated therapy
- Towards precision psychotherapy: Leveraging session-level data to predict session-by-session treatment outcomes
- MicroRNAs expression changes associated with trauma-focused psychotherapy efficacy in treatment-resistant depression: An exploratory study
- Survival benefits and prognostic models of surgical resection versus continued medical treatment in CNLC stage IIb/IIIa hepatocellular carcinoma after meeting resectability criteria following conversion therapy
- The Next Frontier in Person-Centered Diabetes Care—From Asking What Matters to Acting on What Matters
BibTeX
@article{souza2026supporting,
title = {{Supporting Video-Based Psychotherapy While Asking Who Benefits and Who Remains in Treatment.}},
author = {Luciano Dias de Mattos Souza and Karen Jansen and Ricardo Azevedo da Silva},
journal = {Journal of medical Internet research},
year = {2026},
month = oct,
doi = {10.2196/113178},
url = {https://europepmc.org/article/MED/42950348},
note = {CC BY},
}
RIS
TY - JOUR
TI - Supporting Video-Based Psychotherapy While Asking Who Benefits and Who Remains in Treatment.
AU - Luciano Dias de Mattos Souza
AU - Karen Jansen
AU - Ricardo Azevedo da Silva
PY - 2026
DA - 2026/10/01
JO - Journal of medical Internet research
DO - 10.2196/113178
UR - https://europepmc.org/article/MED/42950348
AB - Unlabelled Meyer-Keirath and colleagues found no significant difference in posttreatment symptoms between video-based and face-to-face psychotherapy. However, the wide confidence interval indicates substantial imprecision, while the prediction interval suggests that comparative effects may vary considerably across settings; neither supports a conclusion of equivalence. For health services, symptom outcomes alone tell only part of the story. Future studies should report, by randomized group, who starts treatment, who discontinues it, and who completes the final assessment. These are distinct outcomes that may differ between delivery formats and affect the interpretation of symptom results. Video-based psychotherapy is a reasonable option, but its value should be assessed across the full treatment pathway. Adequately powered noninferiority trials should identify which patients can access, remain in, and benefit from each format.
SN - 1439-4456
SN - 1438-8871
ER -